A novel sORF gene mutant strain of Yersinia pestis vaccine EV76 offers enhanced safety and improved protection against plague
Xiao Guo,Youquan Xin,Zehui Tong,Shiyang Cao,Yuan Zhang,Gengshan Wu,Hongyan Chen,Tong Wang,Yajun Song,Qingwen Zhang,Ruifu Yang,Zongmin Du
DOI: https://doi.org/10.1371/journal.ppat.1012129
IF: 7.464
2024-03-29
PLoS Pathogens
Abstract:We recently identified two virulence-associated small open reading frames (sORF) of Yersinia pestis , named yp1 and yp2 , and null mutants of each individual genes were highly attenuated in virulence. Plague vaccine strain EV76 is known for strong reactogenicity, making it not suitable for use in humans. To improve the immune safety of EV76, three mutant strains of EV76, Δ yp1 , Δ yp2 , and Δ yp1&yp2 were constructed and their virulence attenuation, immunogenicity, and protective efficacy in mice were evaluated. All mutant strains were attenuated by the subcutaneous ( s . c .) route and exhibited more rapid clearance in tissues than the parental strain EV76. Under iron overload conditions, only the mice infected with EV76Δ yp1 survived, accompanied by less draining lymph nodes damage than those infected by EV76. Analysis of cytokines secreted by splenocytes of immunized mice found that EV76Δ yp2 induced higher secretion of multiple cytokines including TNF-α, IL-2, and IL-12p70 than EV76. On day 42, EV76Δ yp2 or EV76Δ yp1&yp2 immunized mice exhibited similar protective efficacy as EV76 when exposed to Y . pestis 201, both via s . c . or intranasal ( i . n .) routes of administration. Moreover, when exposed to 200–400 LD 50 Y . pestis strain 201Δ caf1 (non-encapsulated Y . pestis ), EV76Δ yp2 or EV76Δ yp1&yp2 are able to afford about 50% protection to i . n . challenges, significantly better than the protection afforded by EV76. On 120 day, mice immunized with EV76Δ yp2 or EV76Δ yp1&yp2 cleared the i . n . challenge of Y . pestis 201- lux as quickly as those immunized with EV76, demonstrating 90–100% protection. Our results demonstrated that deletion of the yp2 gene is an effective strategy to attenuate virulence of Y . pestis EV76 while improving immunogenicity. Furthermore, EV76Δ yp2 is a promising candidate for conferring protection against the pneumonic and bubonic forms of plague. Y . pestis , the causative agent of the deadly plague, has caused three global pandemics throughout history and continues to pose a significant threat in various regions of the world. Unfortunately, there are currently no approved vaccines available to safeguard humans against Y . pestis infection. While the live-attenuated Y . pestis EV76 vaccine strain has been utilized in high-risk populations in China, Mongolia, and former Soviet countries, its usage is restricted due to potential severe adverse effects. In a recent study, we identified two small open reading frames (sORF)-encoded peptides of Y . pestis , namely SEP-yp1 and SEP-yp2, which are associated with the bacterium's virulence. To improve the safety and efficacy of the EV76 vaccine, we constructed three mutant strains (Δ yp1 , Δ yp2 , and Δ yp1&yp2 ) and evaluated their virulence attenuation, immunogenicity, and ability to protect against Y . pestis infection in mice. Our findings demonstrated that deleting the yp2 gene was a successful approach to diminish the virulence of Y . pestis EV76 while simultaneously enhancing its ability to provoke an immune response. Furthermore, our study revealed that EV76Δ yp2 exhibited superior protection against different forms of plague, including pneumonic and bubonic, making it a promising candidate for further development as a plague vaccine.
microbiology,virology,parasitology